Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID‐19: The Swiss COVID‐HEP randomized clinical trial

BACKGROUND: Hospitalized patients with COVID‐19 suffered initially from high rates of venous thromboembolism (VTE), with possible associations between therapeutic anticoagulation and better clinical outcomes in observational studies. OBJECTIVE: To test whether therapeutic anticoagulation improves cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Blondon, Marc, Cereghetti, Sara, Pugin, Jérôme, Marti, Christophe, Darbellay Farhoumand, Pauline, Reny, Jean‐Luc, Calmy, Alexandra, Combescure, Christophe, Mazzolai, Lucia, Pantet, Olivier, Ltaief, Zied, Méan, Marie, Manzocchi Besson, Sara, Jeanneret, Séverin, Stricker, Hans, Robert‐Ebadi, Helia, Fontana, Pierre, Righini, Marc, Casini, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116142/
https://www.ncbi.nlm.nih.gov/pubmed/35599701
http://dx.doi.org/10.1002/rth2.12712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116142/
https://www.ncbi.nlm.nih.gov/pubmed/35599701
http://dx.doi.org/10.1002/rth2.12712

Ejemplares similares